BACKGROUND: Out-of-pocket expenditures are thought to be an important barrier to the receipt of cancer preventive services, especially for those of a lower socioeconomic status (SES). The Affordable Care Act (ACA) eliminated out-of-pocket expenditures for recommended services, including mammography and colonoscopy. The objective of this study was to determine changes in the uptake of mammography and colonoscopy among fee-for-service Medicare beneficiaries before and after ACA implementation. METHODS: Using Medicare claims data, this study identified women who were 70 years old or older and had not undergone mammography in the previous 2 years and men and women who were 70 years old or older, were at increased risk for colorectal cancer, and had not undergone colonoscopy in the past 5 years. The receipt of procedures in the 2-year period before the ACA's implementation (2009)(2010) and after its implementation (2011 to September 2012) was also identified. Multivariate generalized estimating equation models were used to determine the independent association and county-level quartile of median income and education with the receipt of testing. RESULTS: For mammography, a lower SES quartile was associated with less uptake, but the post-ACA disparities were smaller than those in the pre-ACA period. In addition, mammography rates increased from the pre-ACA period to the post-ACA period in all SES quartiles. For colonoscopy, in both the pre-and post-ACA periods, there was an association between uptake and educational level and, to some extent, income. However, there were no appreciable changes in colonoscopy and SES after implementation of the ACA. CONCLUSIONS: The removal of out-of-pocket expenditures may overcome a barrier to the receipt of recommended preventive services, but for colonoscopy, other procedural factors may remain as deterrents. Cancer 2017;123:1585-9.
INTRODUCTION
The Affordable Care Act (ACA), which was signed into law in 2010 and whose phased-in implementation began in 2011, provided expanded health care insurance coverage to previously uninsured or underinsured individuals. Although the major objectives of the ACA were to be achieved through Medicaid expansion, insurance mandates, and the elimination of exclusions for preexisting conditions, another goal was to eliminate out-of-pocket expenditures for preventive services that were approved by the US Preventive Services Task Force, including screening mammography and colonoscopy. The reduction of financial barriers to the receipt of cancer screening is thought to be an important step in eliminating known socioeconomic disparities in the incidence of cancer and the stage of cancer at presentation. 1 Although it is assumed that the elimination of out-of-pocket expenses will reduce disparities, there is little empirical evidence to support this contention. Previous studies have reported inconsistent findings with respect to changes in screening after the passage of the ACA, [2] [3] [4] [5] [6] [7] and few have compared changes across socioeconomic strata. Therefore, we examined the uptake of mammography and colonoscopy according to the county-level socioeconomic status (SES) among fee-forservice Medicare beneficiaries in the 2-year period before the ACA (2009) (2010) and in the 2 years after implementation of the ACA (2011-2012).
MATERIALS AND METHODS
The design of the study has been previously reported. 8 In brief, we used a 5% random sample of fee-for-service Medicare beneficiaries who were 70 years old or older and were continuously enrolled in Medicare Parts A and B. Files included the 2009-2012 Medicare Provider Analysis and Review, outpatient and carrier or physician claim files, and Medicare Beneficiary Summary files, which contain enrollment data. On the basis of their most recent screening procedure date, we identified women who had not undergone mammography in the last 24-month period and men and women who were at increased risk for colorectal cancer (previous polyp diagnosis or polypectomy, inflammatory bowel disease, or family history of colon cancer) and had not undergone colonoscopy in the past 5 years. Using previously developed algorithms, the analysis was limited to procedures that were performed for preventive indications rather than diagnostic indications. 9, 10 We excluded beneficiaries who were enrolled in Medicare because of endstage renal disease or disability or because of a diagnosis of cancer or carcinoma in situ during the previous 5-year period. Because of the need to have a 5-year look-back period, we excluded beneficiaries aged 65 to 69 years, and eligible patients entered the sample at the age of 70 years.
Because Medicare files do not contain beneficiarylevel SES, using the 2010 US Census data, we included the county-level median household income and proportion of high school graduates among adults aged 25 years or older as a proxy. These measures were stratified by quartile. Other measures included the following: demographic characteristics (age, race, and sex for colonoscopy), geographic region (Northeast, Midwest, South, or West), comorbidity score, 11 receipt of Medicare wellness visits or welcome-to-Medicare visits, presence of additional breast cancer risk factors (including benign breast neoplasms, abnormal findings on radiological and other breast examinations, complications due to breast prostheses, Cowden syndrome, personal history of chest irradiation, and family history of breast or ovarian cancer [for mammography]), and county density of primary care providers and county density of gastroenterologists (for colonoscopy) as measured by the 2010 American Medical Association Masterfile.
Because individual patients were eligible for screening in more than 1 year, patient-level generalized estimating equation logistic regression was used to account for within-patient correlation. Multivariate generalized estimating equation models were used to determine the independent association of quartiles of SES measures with the receipt of testing, and we calculated the odds ratio for the receipt of procedures within each SES quartile. Analyses were performed for the 2-year period before ACA implementation (2009-2010) and the 2-year period after implementation (2011 to September 2012). The models included an indicator variable for the time period as well as interactions between the period and the income and education quartiles. The resulting models allowed the effects of education and income quartiles to vary between the 2 periods and allowed us to test whether relations between screening and these factors changed from the pre-ACA period to the post-ACA period. The study was approved by the University Hospital Institutional Review Board.
RESULTS
The sample included 862,267 women for the mammography analysis. In the mammography sample, the mean age was 79.7 6 6.9 years, 86.5% were white, and 8.2% were African American. More than 16% had evidence of increased breast cancer risk, and 57.2% had undergone 1 or more mammograms within the previous 5 years. The estimated odds ratios for the effects of the income and education quartiles for the pre-and post-ACA periods are shown (Tables 1 and 2 ). Although for both time periods there appeared to be an association between a lower SES quartile and less receipt of mammography (Table 1) , after implementation of the ACA, the odds ratios differed . In addition, significant interaction with the time period was found for the effects of income and education. We then compared screening rates in the post-ACA period with rates before the ACA within each category of income and education quartile ( Table 2 ). These data indicate that mammography rates increased from the pre-ACA period to the post-ACA period in all categories.
The sample included 326,503 men and women for the colonoscopy analysis. In the colonoscopy sample, the mean age was 77.1 6 6.1 years, 59% were female, 89.9% were white, and 6.3% were African American. There was evidence of the receipt of colonoscopy in the past 5 years for 68%. The estimated odds ratios for the effects of income and education quartiles for the pre-and post-ACA periods are shown (Tables 3 and 4) . In both the pre-and post-ACA periods, there was an association of the educational level and, to some extent, income with the receipt of colonoscopy (Table 3) . However, in contrast to mammography, there were no appreciable changes after implementation of the ACA. For example, in comparison with the highest quartile, the odds ratio for the lowest quartile was 0.94 (95% CI, 0.91-0.97) before the ACA and 0.92 (95% CI, 0.90-0.95) after the ACA for income and 0.96 (95% CI, 0.93-0.99) before the ACA and 1.00 (95% CI, 0.97-1.03) after the ACA for education (P 5 .40 for a comparison of the time periods for income and P 5 .07 for education). The interaction tests indicate that the effects of income, education, and quartile did not differ significantly between the 2 time periods, and this is consistent with the results of the more specific tests. In addition, odds ratios comparing colonoscopy rates before and after the ACA indicated a slight decrease in uptake (Table 4) .
DISCUSSION
It has been well documented that members of lower socioeconomic groups are less likely to receive cancer preventive services. For example, data from the 2013 National Health Interview Survey indicate differences in colorectal endoscopy, fecal occult blood testing, mammography, Papanicolaou testing, and prostate-specific antigen testing according to the level of education and the presence of health insurance. 12 Thus, the elimination or reduction of out-of-pocket expenditures should ideally reduce these disparities. Using a cohort of Medicare beneficiaries, we found that after implementation of the ACA, not only was there an increase in mammography uptake, but the gap in the receipt of mammography between the lowest and highest SES strata narrowed. In contrast, overall colonoscopy uptake did not differ substantively across strata and was stagnant with no change in any observed disparities after implementation of the ACA. Although screening mammography and colonoscopy were covered benefits under Medicare before implementation of the ACA, beneficiaries were responsible for paying 20% coinsurance for mammography and 25% coinsurance for colonoscopy. For diagnostic mammography or colonoscopy, including colonoscopy with preventive indications resulting in biopsy or polypectomy, beneficiaries were also responsible for the annual deductible. After implementation of the ACA, both coinsurance and deductibles were waived for screening examinations, but for diagnostic indications, beneficiaries were still responsible for coinsurance.
Previous studies have used changes in reimbursement policy to examine the impact of decreased out-ofpocket expenditures on procedure uptake. In 1991, when screening mammography was first reimbursed under Medicare, rates of mammography remained similar to those of the previous year, although they were consistently lower for women who lacked supplemental insurance. 13 In 1998, Medicare coverage changed from biennial mammography to annual mammography, and this policy change was associated with a decrease in advanced-stage cancers among women enrolled in fee-for-service plans rather than managed-care plans.
14 However, out-ofpocket expenditures continued to be a barrier to the receipt of mammography, as demonstrated in a study of Medicare managed-care enrollees. 15 Overall colonoscopy use increased after coverage of screening colonoscopy for high-risk individuals, 10 and it increased further after universal coverage in July 2001. 16, 17 In patients younger than 65 years, state mandates for insurance coverage for screening colonoscopy have been associated with higher screening rates. 18 However, none of the aforementioned studies examined the impact of these changes on known socioeconomic disparities in screening.
More recently, studies have examined changes in screening procedures in health plans 4, 5, 7 and Medicare beneficiaries 3, 6 after implementation of the ACA and have found either no substantive change in screening or increases only in a subgroup of patients. Although most studies did not stratify their findings by SES, one study of a high-deductible health plan found that colorectal screening rates increased after the ACA, but the change was limited to higher income individuals. 7 The current findings contrast with those of 2 cross-sectional studies. Fedewa et al 2 used National Health Interview Survey data and found an increase in colon cancer screening from 2008 to 2013 among Medicare beneficiaries and individuals with lower income and educational attainment and no overall change in mammography uptake. Hamman and Kapinos 6 used Behavioral Risk Factor Surveillance System data and found an increase in colorectal screening in men but not women after the ACA, with the largest increase in socioeconomically disadvantaged men. However, our methodology differed in that the same population was examined before and after the ACA, and thus it accounted for pre-ACA screening behavior. In addition, our study included a colonoscopy population with additional risk factors, so these individuals may exhibit different behavior than an average-risk population.
We acknowledge several limitations of the data. First, the administrative data lack clinical detail, including the ability to differentiate between screening and diagnostic indications, although we used previously developed algorithms to select screening procedures. The study also did not examine beneficiaries who were enrolled in Medicare advantage plans but focused on the impact of reform changes among fee-for-service enrollees. The analysis was also limited to an older patient population that was predominantly Caucasian, and thus the impact of reform legislation in other populations, including younger, privately insured, or predominantly minority individuals, could not be measured. Although routine screening colonoscopy is not universally recommended past the age of 75 years, for patients at increased cancer risk, such as those in this study, there is no upper age limit. Another limitation is the lack of data on supplemental or Medigap insurance because individuals with such insurance would not be subject to out-of-pocket expenses for diagnostic procedures. However, the presence of Medigap insurance would have the greatest effect in the pre-ACA period, when out-ofpocket expenses were greater. The current legislation also does not waive copayments for colonoscopy with biopsy or polypectomy for Medicare beneficiaries, even if the procedure indication is preventive, and it is unknown if this loophole has served as a deterrent to colonoscopy uptake. Finally, because patient-level SES data were not available in the claims data, we used small area measures; this is an approach commonly used in studies of Medicare data. However, we acknowledge that within a given region, there is some degree of heterogeneity in SES. Although we were unable to measure a direct cause and effect relation, we found that after implementation of the ACA, there was reduction in socioeconomic disparities for screening mammography but not colonoscopy. The findings support the removal of out-of-pocket expenditures as a barrier to the receipt of recommended preventive services but emphasize that for colonoscopy, other factors such as a fear of sedation, perceived discomfort, and a need for bowel preparation should be considered. We suggest that future studies examine the ACA's impact in other populations, including newly insured individuals. 
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